GSA CAPITAL PARTNERS LLP - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 188 filers reported holding DENALI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$772
-99.7%
37,404
+439.0%
0.07%
+120.0%
Q1 2022$223,000
-14.2%
6,940
+19.0%
0.03%
-9.1%
Q4 2021$260,000
-65.4%
5,834
-60.8%
0.03%
-57.1%
Q3 2021$751,000
+135.4%
14,892
+166.7%
0.08%
+45.3%
Q1 2021$319,000
-39.9%
5,583
-78.2%
0.05%
-10.2%
Q2 2019$531,000
+145.8%
25,564
+174.3%
0.06%
+168.2%
Q1 2019$216,0009,3200.02%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Crestline Management, LP 7,705,039$343,645,00025.68%
Casdin Capital, LLC 1,500,000$66,900,0001.89%
Flagship Pioneering Inc. 2,619,968$116,851,0001.81%
SECTORAL ASSET MANAGEMENT INC 189,600$8,456,0001.27%
Integral Health Asset Management, LLC 100,000$4,460,0001.23%
Temasek Holdings (Private) Ltd 5,369,487$239,479,0000.86%
Goldstream Capital Management Ltd 78,418$3,497,0000.86%
Yiheng Capital Management, L.P. 335,184$14,949,0000.76%
GILDER GAGNON HOWE & CO LLC 2,900,114$129,345,0000.74%
Artal Group S.A. 600,000$26,760,0000.73%
View complete list of DENALI THERAPEUTICS INC shareholders